Flavoxate is an anticholinergic with antimuscarinic effects, it is used as a medication for its muscle relaxant properties. Where it is used to treat urinary bladder spasms and other similar ailments. It is produced by manufacturers under the trade names of Urispas (Paladin, India), Genurin (Recordati, Italy), Uritac (El Saad company, Syria), Bladderon (Nippon Shinyaku, Japan), Bladuril (Chile), and Utispas (Apex Pharma, Nepal). Flavoxate was originally approved for use in the United States in 1970 and since has become popular in the global medical marketplace. Where, due to its emergence into the generic drugs space, it has seen frequent production and commercialization by flavoxate manufacturers and flavoxate suppliers. It is now often found on the pharmaceutical products for sale list of global distributors, where it is available for wholesale order at a variety of cost and price points.
Method of action of flavoxate:
Flavoxate belongs to a group of drugs which function as spasmolytic flavone derivatives and it specifically functions by relaxing the smooth muscles in the urinary tract. Although the exact mechanism of action remains elusive, it is known that flavoxate functions as a direct antagonist at muscarinic acetylcholine receptors in cholinergic innervated organs. This anticholinergic and parasympatholytic effect reduces the tonus of smooth muscle in the bladder, causing a reduction in the need to urinate and an increase in retention and subsequent volume per urination.
Form and dosage of flavoxate:
The final form and packaging are dependent on the manufacturers and suppliers, as well as the specific distributors and order. However, flavoxate typically comes in forms including tablets, film-coated tablets, and capsules. The recommended dose for adult patients for all clinical indications is 200 mg 3 times a day, taken by mouth. Special caution and subsequent dose adjustment should be taken with the elderly and young. Side effects are predominantly non-serious and include constipation, dizziness, and drowsiness. For a complete list of possible complications and additional information please refer to the manufacturers’ literature or an accredited healthcare provider.
Flavoxate on Pipelinepharma:
Currently, at the time of writing, we have found 2 verified flavoxate manufacturers and flavoxate suppliers from our online global list of B2B sellers. These manufacturers, suppliers, and distributors are located in countries including Egypt and Lebanon. Each company and their pharmaceutical products list displayed on our online B2B platform has been verified by the Pipelinepharma team. This ensures seller reputability and reduces sourcing mileage, allowing for a fluent business experience for all involved parties.
Price of flavoxate and how to buy:
A cursory search online reveals an approximate wholesale cost for flavoxate to be £11.67 for 200 mg x 90 tablets. These values are indicated for the NHS in the UK. As such they are only intended to serve as a generalization of the current market conditions.
Although the prices on the B2B wholesale Pipelinepharma marketplace remain confidential between both B2B parties, the seller may choose to list the desired price to facilitate the online transaction. If so, an ‘Accept’ and ‘Negotiate’ button will be displayed through the online interface, with a ‘Get offer’ button being shown in the absence. This makes it easy to find new qualified sellers for your pharmaceutical business. Simply use our online search tool, filter by your wanted criteria, and finally select the desired listing.